PharmNovo AB
PrivateLast Round
VC Round
Jul 9, 2026
Est. Valuation
$10.34M
Total Funding Raised
$5.23M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PharmNovo AB is a clinical-stage pharmaceutical company that develops novel drug candidates for the treatment of neuropathic pain and other nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharmNovo AB Comparables
Compare PharmNovo AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biodol Therapeutics | 84% | |
| Algiax Pharmaceuticals | 83% | |
| Confo Therapeutics | 82% |
PharmNovo AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 9, 2026 | ||||
| Grant | Jul 17, 2024 | ||||
| VC Round | Jun 3, 2022 | ||||
| Seed | Oct 20, 2020 |
Key People
Founding team and executive leadership
PharmNovo AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Almi Invest AB | Seed |
| Sciety | VC Round, Seed |
| KDventures AB | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 132% MoM.
- Jul 25, 2026
Monthly visitors grew 51% MoM, reaching 1.6K.
PharmNovo AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PharmNovo AB's valuation, stock price, and market status.
Is PharmNovo AB a public or private company?
PharmNovo AB is a private company.
What is the current stock price of PharmNovo AB?
PharmNovo AB is a private company, so its shares have no public market price. Caplight tracks PharmNovo AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PharmNovo AB worth (valuation)?
PharmNovo AB's valuation is estimated at $10.3M based on funding round data.
Can I buy PharmNovo AB stock?
PharmNovo AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PharmNovo AB's last funding round?
PharmNovo AB's most recent funding round was VC Round on July 9, 2026.
Who are the main investors in PharmNovo AB?
Key investors in PharmNovo AB include Sciety.
Will PharmNovo AB IPO soon?
No public IPO plans have been announced for PharmNovo AB.
How can I track PharmNovo AB secondary market activity?
Caplight tracks bids, offers, and trades in PharmNovo AB's shares on secondary markets.